Enliven Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $516k | 25k | 20.47 |
| 2025-06-30 | $451k | 23k | 20.06 |
| 2025-03-31 | $542k | 28k | 19.68 |
| 2024-12-31 | $687k | 31k | 22.50 |
| 2024-09-30 | $514k | 20k | 25.54 |
| 2024-06-30 | $356k | 15k | 23.37 |
| 2024-03-31 | $193k | 11k | 17.59 |
| 2023-12-31 | $147k | 11k | 13.84 |
| 2023-09-30 | $149k | 11k | 13.66 |
| 2023-06-30 | $190k | 9.3k | 20.41 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft